Clinical Trials Directory

Trials / Completed

CompletedNCT02024464

Comparing Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery

A Prospective, Multicenter, Randomized Comparison of the Hydrus Microstent to the iStent for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
306 (actual)
Sponsor
Ivantis, Inc. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This clinical trial compares two implantable devices intended to lower the pressure inside the eye of glaucoma patients. One of the two devices will be implanted immediately following cataract surgery and the placement of a posterior chamber intra-ocular lens. Only one eye (study eye) will be implanted.

Detailed description

This is a prospective, multicenter, single-masked, randomized clinical trial comparing Cataract Extraction (CE) + Hydrus Microstent to CE surgery + iStent implant for the reduction of intraocular pressure in patients with a positive diagnosis of primary open angle glaucoma, pseudoexfoliative glaucoma, or pigmentary dispersion glaucoma with an operable cataract. Eligible patients will be scheduled for cataract surgery. At the conclusion of successful cataract surgery and the placement of a posterior-chamber IOL, qualified subjects will be randomized to receive either the Hydrus Microstent or the iStent implant. Post-operative follow-up visits will be conducted at regular intervals.

Conditions

Interventions

TypeNameDescription
DEVICEHydrus MicrostentDevice inserted into Schlemm's canal to enhance aqueous flow from the anterior chamber.
DEVICEiStent Trabecular Micro BypassDevice inserted into Schlemm's canal to enhance aqueous flow from the anterior chamber.
PROCEDURECataract removal and intraocular lens (IOL) implantationCataract removal with phacoemulsification using standard techniques, followed by implantation with a posterior-chamber IOL suitable for glaucoma subjects

Timeline

Start date
2011-08-01
Primary completion
2017-03-01
Completion
2018-08-01
First posted
2013-12-31
Last updated
2024-07-03
Results posted
2024-06-21

Source: ClinicalTrials.gov record NCT02024464. Inclusion in this directory is not an endorsement.